Clinical Trials Logo

Heart Rhythm Disorders clinical trials

View clinical trials related to Heart Rhythm Disorders.

Filter by:
  • None
  • Page 1

NCT ID: NCT03945968 Recruiting - Stroke Clinical Trials

The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.

STOPRISK
Start date: July 1, 2019
Phase:
Study type: Observational

Study is conducted to assess the prevalence and structure of comorbidity among patients undergoing abdominal surgery and produce the stratification of the risk of postoperative complications by identifying independent predictors for its development.

NCT ID: NCT03835169 Completed - Clinical trials for Acute Coronary Syndrome

Intra Hospital Mortality Risk Factors in Patients Admitted to Cardiac Intensive Care Units in 2017 in France

USIC -BNAT
Start date: January 24, 2019
Phase:
Study type: Observational

Retrospective, observational cohort study. Objectives: To identify intra hospital mortality risk factors in patients admitted admitted to cardiac intensive care units (CICU). The clinical main endpoint will be the observed percentage of deaths that occured during the year 2017 in french CICU. To identify the length of stay key determiners of patients admitted in french CICU. The study will use data from one of the french nationwide healthcare systems database (SNDS) : the national hospital discharge database (PMSI) to be precise.

NCT ID: NCT01888315 Recruiting - Hypertension Clinical Trials

Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity

Start date: January 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The study is aiming to document the long-term safety and effectiveness of renal denervation in patients with hypertension and other diseases characterized by elevated sympathetic drive. Catheter-based renal denervation will be performed using CE marked, percutaneous, systems.

NCT ID: NCT01723566 Completed - Clinical trials for Heart Rhythm Disorders

PANORAMA 2 Observational Study

Start date: July 25, 2012
Phase: N/A
Study type: Observational

Understanding the clinical practice of treatment of cardiac rhythm disorders all over the world and understanding the clinical outcomes of the treatment with its cardiac rhythm products in real world patient population is essential for Medtronic to be able to effectively develop new products and adjust existing products. In addition Medtronic is committed to monitor the safety of its products throughout the entire life cycle to ensure maximum product reliability. The Panorama 2 registry will enable Medtronic to increase data collection of clinical practice with Medtronic implantable Cardiac Rhythm and Disease Management (CRDM) devices in various regions across the world and on product reliability of its CRDM devices.